Showing 4 of 4 recruiting trials for “obsolete-epidermolysis-bullosa-simplex-superficialis”
A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex
A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses
👨⚕️ Christine Chiaverini, Centre Hospitalier Universitaire de Nice📍 2 sites📅 Started Mar 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →